OM:DVYSRBiotechs
Devyser Diagnostics (OM:DVYSR) Q4 EPS Turn To SEK0.82 Tests Bearish Profitability Narrative
Devyser Diagnostics (OM:DVYSR) has opened 2026 with a mixed scorecard, coming off Q4 2025 revenue of SEK72 million and basic EPS of SEK0.82, following a year in which trailing twelve month EPS stood at a loss of SEK0.51 on revenue of SEK250.5 million. Over recent quarters the company has seen revenue move between SEK48.7 million in Q3 2024 and SEK72 million in Q4 2025, while quarterly EPS has ranged from a loss of SEK1.41 per share in Q3 2024 to a profit of SEK0.82 per share in Q4 2025. This...